Sort
78,016 grants matching “breast cancer”
WNT pathway-driven anti-estrogen therapy resistance in breast cancer
$549,696Hallgeir Rui · Thomas Jefferson University · R01 · FY2025 · CA
Delineating Functional Immunity via Image-Guided PET
$549,663Nerissa Therese Viola · Wayne State University · R37 · FY2019 · CA
PET Imaging of Cancer with pH (Low) Insertion Peptide (pHLIP)
$549,660Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Decisions & Outcomes of BRCA1/2 Test for Breast Patients
$549,658Marc D Schwartz · Georgetown University · R01 · FY2006 · CA
Noninvasive deep-tissue single-cell imaging and nanoprobe development
$549,629Steven Chu · Stanford University · R01 · FY2020 · GM
Screening for Breast Cancer Using Molecular Signatures
$549,601H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2004 · CA
Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity
$549,598David G Denardo · Washington University · R01 · FY2023 · CA
Noninvasive deep-tissue single-cell imaging and nanoprobe development
$549,581Steven Chu · Stanford University · R01 · FY2021 · GM
Virtual Clinical Trials: Simulation of Digital Breast Tomosynthesis Screening
$549,578Andrew Douglas Arnold Maidment · University Of Pennsylvania · R01 · FY2014 · CA
DEVELOPING A NOVEL PROTAC-BASED NR4A1 DEGRADER FOR BREAST CANCER THERAPY
$549,557University Of Florida · · FY2021 · Defense Health Agency
Noninvasive deep-tissue single-cell imaging and nanoprobe development
$549,540Steven Chu · Stanford University · R01 · FY2019 · GM
Noninvasive deep-tissue single-cell imaging and nanoprobe development
$549,537Steven Chu · Stanford University · R01 · FY2018 · GM
3D wearable NIR spectral tomography for early prediction of breast cancerâs residual cancer burden after neoadjuvant chemotherapy
$549,536Shudong Jiang · Dartmouth College · R01 · FY2024 · CA
Quantitative Subharmonic Breast Imaging
$549,525Flemming Forsberg · Thomas Jefferson University · R01 · FY2011 · CA
Multiscale analysis of metabolic inflammation as a driver of breast cancer
$549,519Gerald V Denis · Boston University Medical Campus · U01 · FY2023 · CA
Integrative Approaches for Cancer Survivorship: A Multi-Site Feasibility and Acceptability Study
$549,516Anand Dhruva · University Of California, San Francisco · R01 · FY2024 · AT
CHARACTERIZING PAFAH1B3 AS A NOVEL METABOLIC TARGET FOR BREAST CANCER THERAPY
$549,488Regents Of The University Of California, The · · FY2015 · Department of the Army
Quantifying and Characterizing the shared genetic contribution to common cancers
$549,469Sara Lindstroem · University Of Washington · U01 · FY2019 · CA
Southern Nevada Cancer Research Foundation--CCOP
$549,418Southern Nevada Cancer Research Fdn · U10 · FY2003 · CA
Characterizing the Risk of Chemotherapy Side Effects Based on Epigenetic Age and Modification by Resistance Training Intervention
$549,396Alexandra Margaret Lynn Binder · University Of Hawaii At Manoa · R37 · FY2021 · CA
TARGETING TRANSCRIPTION ELONGATION MACHINERY FOR BREAST CANCER THERAPY
$549,364Regents Of The University Of California, The · · FY2015 · Department of the Army
Delineating the dystopian nature of the cell cycle in cancer
$549,360Erik Knudsen · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Cook For Your Life: Maintaining diet and physical activity changes in Latina breast cancer survivors
$549,310Heather A Greenlee · Columbia University Health Sciences · R01 · FY2018 · CA
Multiparameter single-cell genomics platform for personalized treatment of cancer
$549,310Eric Brouzes · State University New York Stony Brook · R01 · FY2016 · CA
Transdermal Nitroglycerin Therapy for Menopausal Hot Flashes
$549,267Alison Huang · University Of California, San Francisco · R01 · FY2018 · AG